148 related articles for article (PubMed ID: 25940195)
1. Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.
Huijben S; Chan BH; Read AF
Am J Trop Med Hyg; 2015 Jun; 92(6):1214-21. PubMed ID: 25940195
[TBL] [Abstract][Full Text] [Related]
2. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections.
de Roode JC; Culleton R; Bell AS; Read AF
Malar J; 2004 Sep; 3():33. PubMed ID: 15367331
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD
Malar J; 2010 May; 9():135. PubMed ID: 20492669
[TBL] [Abstract][Full Text] [Related]
4. Virulence, drug sensitivity and transmission success in the rodent malaria, Plasmodium chabaudi.
Schneider P; Bell AS; Sim DG; O'Donnell AJ; Blanford S; Paaijmans KP; Read AF; Reece SE
Proc Biol Sci; 2012 Nov; 279(1747):4677-85. PubMed ID: 23015626
[TBL] [Abstract][Full Text] [Related]
5. The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection.
Huijben S; Sim DG; Nelson WA; Read AF
J Evol Biol; 2011 Nov; 24(11):2410-22. PubMed ID: 21883612
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial drugs clear resistant parasites from partially immune hosts.
Cravo P; Culleton R; Hunt P; Walliker D; Mackinnon MJ
Antimicrob Agents Chemother; 2001 Oct; 45(10):2897-901. PubMed ID: 11557487
[TBL] [Abstract][Full Text] [Related]
7. Fitness of drug-resistant malaria parasites.
Walliker D; Hunt P; Babiker H
Acta Trop; 2005 Jun; 94(3):251-9. PubMed ID: 15845348
[TBL] [Abstract][Full Text] [Related]
8. On the contribution of the rodent model Plasmodium chabaudi for understanding the genetics of drug resistance in malaria.
Cravo P
Parasitol Int; 2022 Dec; 91():102623. PubMed ID: 35803536
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.
Huijben S; Nelson WA; Wargo AR; Sim DG; Drew DR; Read AF
Evolution; 2010 Oct; 64(10):2952-68. PubMed ID: 20584075
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium chabaudi: effect of antimalarial drugs on gametocytogenesis.
Buckling A; Crooks L; Read A
Exp Parasitol; 1999 Sep; 93(1):45-54. PubMed ID: 10464038
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria.
Bell AS; Huijben S; Paaijmans KP; Sim DG; Chan BH; Nelson WA; Read AF
PLoS One; 2012; 7(6):e37172. PubMed ID: 22701563
[TBL] [Abstract][Full Text] [Related]
12. A high-coverage artificial chromosome library for the genome-wide screening of drug-resistance genes in malaria parasites.
Iwanaga S; Kaneko I; Yuda M
Genome Res; 2012 May; 22(5):985-92. PubMed ID: 22426943
[TBL] [Abstract][Full Text] [Related]
13. MDR1-associated resistance to artesunate+mefloquine does not impair blood-stage parasite fitness in a rodent malaria model.
Rodrigues L; Henriques G; Cravo P
Infect Genet Evol; 2013 Mar; 14():340-6. PubMed ID: 23318648
[TBL] [Abstract][Full Text] [Related]
14. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
15. Does the drug sensitivity of malaria parasites depend on their virulence?
Schneider P; Chan BH; Reece SE; Read AF
Malar J; 2008 Dec; 7():257. PubMed ID: 19087299
[TBL] [Abstract][Full Text] [Related]
16. Of mice and malaria mutants: unravelling the genetics of drug resistance using rodent malaria models.
Carlton JM; Hayton K; Cravo PV; Walliker D
Trends Parasitol; 2001 May; 17(5):236-42. PubMed ID: 11323308
[TBL] [Abstract][Full Text] [Related]
17. Is the expression of genes encoding enzymes of glutathione (GSH) metabolism involved in chloroquine resistance in Plasmodium chabaudi parasites?
Ferreira ID; Nogueira F; Borges ST; do Rosário VE; Cravo P
Mol Biochem Parasitol; 2004 Jul; 136(1):43-50. PubMed ID: 15138066
[TBL] [Abstract][Full Text] [Related]
18. Experimental evolution of resistance to artemisinin combination therapy results in amplification of the mdr1 gene in a rodent malaria parasite.
Rodrigues LA; Henriques G; Borges ST; Hunt P; Sanchez CP; Martinelli A; Cravo P
PLoS One; 2010 Jul; 5(7):e11593. PubMed ID: 20657645
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
He Z; Chen L; You J; Qin L; Chen X
Exp Parasitol; 2009 Oct; 123(2):122-7. PubMed ID: 19538959
[TBL] [Abstract][Full Text] [Related]
20. Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites.
Pollitt LC; Huijben S; Sim DG; Salathé RM; Jones MJ; Read AF
PLoS Pathog; 2014 Apr; 10(4):e1004019. PubMed ID: 24763470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
